2011 - IPITA - Prague


This page contains exclusive content for the member of the following sections: TTS, IPITA. Log in to view.

Poster

1.159 - Thessification of surgical complication applied to pancreas transpklantation: single center experience

Presenter: R. , Garcia-Roca, ,
Authors: R. Garcia-Roca, G. Spoletini, J. Samame, G. Diaz del Gobbo1, M.J. Ricart1

P-159

Thessification of surgical complication applied to pancreas transpklantation: single center experience

R. Garcia-Roca, G. Spoletini, J. Samame, G. Diaz del Gobbo1, M.J. Ricart1
Hospital Clinico Barcelona, Barcelona, Spain

Introduction: Complicaitons in transplantation are expressed in terms of graft outcomes, factoring surgical technique, donor and recipient characteristics. We evaluate the applicability of the Clavien-Dindo classification to pancreas transplantation (type-C intervention) and the impact on graft outcomes.

Methods: Retrospective analysis of 249 pancreas transplants over 10yrs. Donor, recipient, transplant procedure and posttransplant complications are analysed. Hemodialysis for delayed renal graft function and immunosuppression-related complications were excluded. The highest graded complication was recorded.

Results: Complication rates were 26.9% Class.I-II, 43% Class-III and 2.4% Class IV-V. Blood transfusion represented 66.7% of Class-II. Thrombosis was the commonest among the IIIa (83.7%) the remaining were colections percuteneously drainageed. In type IIIb, bleeding occurred in 48.4%, thrombosis in 20.3% and anastomotic leak in 21.6%. Patient and procedure demographics are presented in table 1.The 1 and 5yr graft survival are 95.2/95.2% for Class I-II, 94.7/94.7% class IIIa, 95.2/74.4% class IIIb and 93.2/67.7 for class IV-V. (p=NS). Failure to treat was considered pancreas removal (n=27), 7 cases during the transplant procedure due to poor organ perfusion, the remaining as a consequence of a complication.

Conclusion: The classification applied to pancreas transplantation doesn't reflect on graft outcomes. Some complications are derived from the treatment required and are expected as normal postoperative course.

None (n=68)

I-II (n=68)

IIIa (n=43)

IIIb (n=64)

IV-V(n=6)

Total (n=249)

/

P-159

Thessification of surgical complication applied to pancreas transpklantation: single center experience

R. Garcia-Roca, G. Spoletini, J. Samame, G. Diaz del Gobbo1, M.J. Ricart1
Hospital Clinico Barcelona, Barcelona, Spain

Introduction: Complicaitons in transplantation are expressed in terms of graft outcomes, factoring surgical technique, donor and recipient characteristics. We evaluate the applicability of the Clavien-Dindo classification to pancreas transplantation (type-C intervention) and the impact on graft outcomes.

Methods: Retrospective analysis of 249 pancreas transplants over 10yrs. Donor, recipient, transplant procedure and posttransplant complications are analysed. Hemodialysis for delayed renal graft function and immunosuppression-related complications were excluded. The highest graded complication was recorded.

Results: Complication rates were 26.9% Class.I-II, 43% Class-III and 2.4% Class IV-V. Blood transfusion represented 66.7% of Class-II. Thrombosis was the commonest among the IIIa (83.7%) the remaining were colections percuteneously drainageed. In type IIIb, bleeding occurred in 48.4%, thrombosis in 20.3% and anastomotic leak in 21.6%. Patient and procedure demographics are presented in table 1.The 1 and 5yr graft survival are 95.2/95.2% for Class I-II, 94.7/94.7% class IIIa, 95.2/74.4% class IIIb and 93.2/67.7 for class IV-V. (p=NS). Failure to treat was considered pancreas removal (n=27), 7 cases during the transplant procedure due to poor organ perfusion, the remaining as a consequence of a complication.

Conclusion: The classification applied to pancreas transplantation doesn't reflect on graft outcomes. Some complications are derived from the treatment required and are expected as normal postoperative course.

None (n=68)

I-II (n=68)

IIIa (n=43)

IIIb (n=64)

IV-V(n=6)

Total (n=249)


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada